1
项与 RPM CD19-mbIL15-CAR-T cells(Eden BioCell) 相关的临床试验Infusion of CD19-Specific Chimeric Antigen Receptor T-cells Produced by Rapid Personalized Manufacture for Patients With Advanced Lymphoid Malignancies
This is an open-label Phase 1 study to determine the feasibility, safety, and the recommended maximum tolerated Dose (MTD) of a single infusion of RPM CD19 mbIL15 CAR-T cells for adult patients. Approximately 24 subjects will be enrolled and it is anticipated approximately 16 subjects will be infused at the varied doses of T cells.
100 项与 RPM CD19-mbIL15-CAR-T cells(Eden BioCell) 相关的临床结果
100 项与 RPM CD19-mbIL15-CAR-T cells(Eden BioCell) 相关的转化医学
100 项与 RPM CD19-mbIL15-CAR-T cells(Eden BioCell) 相关的专利(医药)
100 项与 RPM CD19-mbIL15-CAR-T cells(Eden BioCell) 相关的药物交易